nifedipine has been researched along with thromboxanes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M | 1 |
| Darius, H; Klaus, W; Latta, G; Schrör, K; Ziegler, R | 1 |
| Blasevich, M; Borghi, A; Galli, C; Petroni, A; Socini, A | 1 |
| Lefer, AM; Nicolaou, KC; Smith, EF | 1 |
| Kubo, K; Nakamizo, N; Shuto, K; Yamada, K | 1 |
| Imai, S; Katano, Y | 1 |
| Davì, G; Fiore, M; Foderà, A; Mattina, A; Mazzola, A; Novo, S; Strano, A | 1 |
| Ito, T; Kai, I; Ogawa, K | 1 |
| Perzborn, E; Towart, R | 1 |
| Kimblad, PO; Steen, S | 1 |
1 trial(s) available for nifedipine and thromboxanes
| Article | Year |
|---|---|
[Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Adult; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Heart Rate; Humans; Male; Nifedipine; Nisoldipine; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1985 |
9 other study(ies) available for nifedipine and thromboxanes
| Article | Year |
|---|---|
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine | 1991 |
Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Brain; Dipyridamole; Male; Microwaves; Nifedipine; Papaverine; Rats; Thromboxane B2; Thromboxanes; Vasomotor System | 1985 |
Mechanism of coronary vasoconstriction induced by carbocyclic thromboxane A2.
Topics: Animals; Calcium; Cats; Coronary Vessels; Female; Male; Nifedipine; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Thromboxane A2; Thromboxanes; Vasoconstriction; Verapamil | 1981 |
Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.
Topics: Angiotensin II; Animals; Benzamides; Blood Platelets; Calcium; Coronary Vessels; Dogs; Histamine; In Vitro Techniques; Male; Mesenteric Arteries; Nifedipine; Norepinephrine; Potassium Chloride; Rabbits; Serotonin; Thromboxane A2; Thromboxanes; Vasoconstriction | 1984 |
The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
Topics: Animals; Blood Platelets; Dipyridamole; Horses; Imidazoles; In Vitro Techniques; Microsomes; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Thromboxane A2; Thromboxanes; Vasodilator Agents | 1983 |
Effects by nifedipine on thromboxane synthesis in vitro and in vivo.
Topics: Adenosine Diphosphate; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Humans; Nifedipine; Platelet Aggregation; Pyridines; Thromboxanes | 1982 |
Effects of peripheral vasodilation caused by verapamil, nifedipine, and nitroglycerin on plasma prostaglandins and thromboxane concentrations.
Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Dinoprost; Dogs; Female; Male; Nifedipine; Nitroglycerin; Prostaglandins; Prostaglandins E; Prostaglandins F; Pyridines; Thromboxane B2; Thromboxanes; Vascular Resistance; Vasodilation; Verapamil | 1982 |
Relaxation of carbocyclic thromboxane A2-induced contractions of isolated coronary arteries by nifedipine.
Topics: Animals; Cats; Coronary Vessels; Dimethyl Sulfoxide; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Papaverine; Potassium Chloride; Pyridines; Thromboxane A2; Thromboxanes | 1982 |
Eliminating the strong pulmonary vasoconstriction caused by Euro-Collins solution.
Topics: Alprostadil; Animals; Constriction, Pathologic; Drug Combinations; Drug Interactions; Endothelium, Vascular; Epoprostenol; Hypertonic Solutions; Models, Biological; Nifedipine; Papaverine; Phenylacetates; Pulmonary Artery; Severity of Illness Index; Sulfonamides; Swine; Thromboxane A2; Thromboxanes; Vasoconstriction; Vasodilator Agents | 1994 |